Research progress on radical concurrent chemoradiotherapy for locally advanced esophageal cancer
10.3760/cma.j.cn113030-20210427-00178
- VernacularTitle:局部晚期食管癌根治性同步放化疗研究进展
- Author:
Shijia WANG
1
;
Zefen XIAO
Author Information
1. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科，北京 100021
- Keywords:
Esophageal neoplasms;
Locally advanced;
Concurrent chemoradiotherapy;
Immunotherapy
- From:
Chinese Journal of Radiation Oncology
2022;31(11):1065-1069
- CountryChina
- Language:Chinese
-
Abstract:
The current standard treatment modality for unresectable locally advanced esophageal cancer is radical concurrent chemoradiotherapy. In this article, research progress on radiotherapy techniques, differences in radiotherapy dose and target volume, exploration in concurrent chemotherapy and immunotherapy was reviewed, aiming to provide reference and evidence for clinical treatment.
